Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Eloxx Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Eloxx Pharmaceuticals Inc. June 22, 202399.1%
-
Keros Therapeutics Inc. June 6, 202377.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 15, 2025 | Keros Therapeutics Inc. | Open-market sale | −2,284,612 | $17.75 | $40,551,863 |
| Oct 15, 2025 | Keros Therapeutics Inc. | Open-market sale | −1,121,045 | $17.75 | $19,898,549 |
| Oct 15, 2025 | Keros Therapeutics Inc. | Open-market sale | −1,226,412 | $17.75 | $21,768,813 |
| Oct 15, 2025 | Keros Therapeutics Inc. | Open-market sale | −155,262 | $17.75 | $2,755,901 |
| Jun 4, 2025 | Keros Therapeutics Inc. | Grant or award | +5,250 | — | — |
Questions about Tomer Kariv
What boards is Tomer Kariv on?
Tomer Kariv sits on the boards of Eloxx Pharmaceuticals Inc. and Keros Therapeutics Inc.
How long has Tomer Kariv served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.